Application of nutrigenomic concepts to Type 2 diabetes mellitus

被引:32
|
作者
Kaput, Jim
Noble, Janelle
Hatipoglu, Betul
Kohrs, Kari
Dawson, Kevin
Bartholomew, Amelia
机构
[1] Univ Calif Davis, Ctr Excellence Nutr Genom, Davis, CA 95616 USA
[2] Univ Illinois, Dept Surg, Lab Nutrigenom Med, Chicago, IL 60612 USA
[3] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA
[4] Univ Illinois, Med Ctr, Nutr & Wellness Ctr, Med Ctr Outpatient Care Ctr, Chicago, IL 60612 USA
关键词
nutrigenomics; Type 2 diabetes mellitus;
D O I
10.1016/j.numecd.2006.11.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The genetic makeup that individuals inherit from their ancestors is responsible for variation in responses to food and susceptibility to chronic diseases such as Type 2 diabetes mellitus (T2DM). Common variations in gene sequences, such as single nucleotide polymorphisms, produce differences in complex traits such as height or weight potential, food metabolism, food-gene interactions, and disease susceptibilities. Nutritional genomics, or nutrigenomics, is the study of how foods affect the expression of genetic information in an individual and how an individual's genetic makeup affects the metabolism and response to nutrients and other bioactive components in food. Since both diet and genes alter one's health and susceptibitity to disease, identifying genes that are regulated by diet and that cause or contribute to chronic diseases could result in the development of diagnostic tools, individualized intervention, and eventually strategies for maintaining health. Translating this research through clinical studies promises contributions to the development of personalized medicine that includes nutritional as well as drug interventions. Reviewed here are the key nutrigenomic concepts that help explain aspects of the development and complexity of T2DM. (C) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:89 / 103
页数:15
相关论文
共 50 条
  • [41] SARCOPENIA AND TYPE 2 DIABETES MELLITUS
    Dionyssiotis, Y.
    Athanassiou, P.
    Papathanasiou, J.
    Trovas, G.
    Kostoglou-Athanassiou, I.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S700 - S701
  • [42] Type 2 diabetes mellitus and osteoarthritis
    Veronese, Nicola
    Cooper, Cyrus
    Reginster, Jean-Yves
    Hochberg, Marc
    Branco, Jaime
    Bruyere, Olivier
    Chapurlat, Roland
    Al-Daghri, Nasser
    Dennison, Elaine
    Herrero-Beaumont, Gabriel
    Kaux, Jean-Francois
    Maheu, Emmanuel
    Rizzoli, Rene
    Roth, Roland
    Rovati, Lucio C.
    Uebelhart, Daniel
    Vlaskovska, Mila
    Scheen, Andre
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2019, 49 (01) : 9 - 19
  • [43] Sleep and type 2 diabetes mellitus
    Brady, Emer M.
    Hall, Andrew P.
    PRACTICAL DIABETES, 2016, 33 (01) : 23 - 26
  • [44] Miglitol for type 2 diabetes mellitus
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1999, 41 (1053): : 49 - 50
  • [45] Type 2 diabetes mellitus and osteoporosis
    Obaya Rebollar, J. C.
    AVANCES EN DIABETOLOGIA, 2010, 26 (02): : 119 - 119
  • [46] Magnesium and type 2 diabetes mellitus
    Orchard, TJ
    ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (18) : 2119 - 2120
  • [47] Pathogenesis of type 2 diabetes mellitus
    Guillausseau, PJ
    Laloi-Michelin, M
    REVUE DE MEDECINE INTERNE, 2003, 24 (11): : 730 - 737
  • [48] Aldosterone and type 2 diabetes mellitus
    Zavatta, Guido
    Casadio, Elena
    Rinaldi, Eleonora
    Pagotto, Uberto
    Pasquali, Renato
    Vicennati, Valentina
    HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2016, 26 (01) : 53 - 59
  • [49] Pioglitazone for type 2 diabetes mellitus
    Richter, B.
    Bandeira-Echtler, E.
    Bergerhoff, K.
    Clar, C.
    Ebrahim, S. H.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (04):
  • [50] Screening for type 2 diabetes mellitus
    Peer, Nasheeta
    Balakrishna, Yusentha
    Durao, Solange
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (05):